RECITALSCo-Marketing Agreement • March 7th, 2007 • Clearwire Corp • Communications services, nec
CO-MARKETING AGREEMENTCo-Marketing Agreement • September 27th, 2022 • Delaware
[entity type and state] (“Company1”) and [full legal name], a Delaware corporation (“Company2”) is effective on the date of the second signature below.
REVISED CO-MARKETING AGREEMENTCo-Marketing Agreement • May 14th, 2013 • Rosetta Genomics Ltd. • Pharmaceutical preparations
This Revised Co-Marketing Agreement (the “Agreement”) dated October 11, 2012, and which has come into effect on 1 September, 2012 (the “Effective Date”) is by and between Rosetta Genomics Ltd., and its subsidiary, Rosetta Genomics Inc., a Delaware corporation, with offices at 3711 Market St., Suite 740, Philadelphia, PA 19104, USA (collectively, the “Company”) and Precision Therapeutics, Inc., a Delaware corporation with offices at 2516 Jane Street, Pittsburgh, PA 15203, USA (“Precision”).
EX-10.4 2 dex104.htm CO-MARKETING AGREEMENT [****] A CONFIDENTIAL PORTION OF THE MATERIAL HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL Execution Copy CO-MARKETING AGREEMENTCo-Marketing Agreement • May 5th, 2020 • New York
This Co-Marketing Agreement (this “Agreement”) is made effective as of March 21, 2007 (the “Effective Date”) between Cambridge Heart, Inc. (“Cambridge”) a Delaware corporation, having its principal place of business at 1 Oak Park Drive, Bedford, MA 01730 and St. Jude Medical, Inc. (“SJM”) a Minnesota corporation, located at One Lillehei Plaza, St. Paul, MN 55117-2000
Co-Marketing AgreementCo-Marketing Agreement • January 20th, 2022
Code], (hereinafter referred to as the "[Insert Name]") and [Insert Partner Name], located at [Insert Partner Street Address], [Insert Partner City], , [Insert Zip Code], (hereinafter referred to as the "[Insert Partner Name]"). [Insert Name] and [Insert Partner Name] shall be collectively referred to as the Parties.
iSOFT completes agreements for new Life Science research toolCo-Marketing Agreement • April 14th, 2011
The move follows a co-marketing agreement with US-based CliniWorks for its AccelFind solutions. CliniWorks has developed the technology behind AccelFind, and provides it as a service, to extract medical knowledge from any type of data, including free text notes, discharge summaries or the structured data contained in electronic medical records and laboratory systems. With the new agreement, iSOFT will market AccelFind as part of its Life Science Solution “powered by CliniWorks” to hospitals and life science companies worldwide.
EX-10.4 2 dex104.htm RESTATED CO-MARKETING AGREEMENT RESTATED CO-MARKETING AGREEMENTCo-Marketing Agreement • May 5th, 2020 • New York
This Restated Co-Marketing Agreement (the “Agreement”) is entered into on July 8, 2008 and effective as of May 5, 2008 (the “Effective Date”), between Cambridge Heart, Inc. (“Cambridge”), a Delaware corporation, and St. Jude Medical, Inc. (“SJM”), a Minnesota corporation.
CO-MARKETING AGREEMENTCo-Marketing Agreement • June 29th, 2004 • Medical Technology Systems Inc /De/ • General industrial machinery & equipment • New York
This Co-Marketing Agreement (this “Agreement”) is made effective _________, 2004 (the “Effective Date”), between Cardinal Health 103, Inc., Cardinal Health 106, Inc. and Cardinal Health 110, Inc. (individually and collectively, “Cardinal Health”), with its principal place of business at 7000 Cardinal Place, Dublin, Ohio 43017, Attn: Mas Kang, facsimile number (614) 757-5331, and Medical Technology Systems, Inc. (“MTS”), with its principal place of business at 12920 Automobile Boulevard, Clearwater, Florida 33762, Attn: Todd Siegel, facsimile number (727) 576-6311. Each of Cardinal Health 103, Inc., Cardinal Health 106, Inc. and Cardinal Health 110, Inc. shall be jointly and severally liable for the obligations of Cardinal Health under this Agreement.
BACKGROUNDCo-Marketing Agreement • September 29th, 2004 • Usa Technologies Inc • Calculating & accounting machines (no electronic computers) • New York
ContractCo Marketing Agreement • February 26th, 2024
With the above named Brokers agreeing thereto consent to the following marketing agreement terms and conditions, in addition to our superseding those relevant terms and conditions to which the Listing Broker and Owners may have previously agreed. This Co-Marketing Agreement must contain the signatures of the Listing Broker, and ALL OWNERS named in the Listing
Full Service “Sequence-to-Manufacturing” Offering Designed to Drive Efficiencies and Reduce Overall Timelines for Delivering Early-Stage CGMP Bulk Drug SubstancesCo-Marketing Agreement • May 6th, 2020
dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, and Aragen Bioscience, a leading contract research organization (CRO) focused on accelerating pre-clinical biologics product development, today announced a co-marketing agreement that will provide clients an integrated “sequence-to-manufacturing” service. Under terms of the non-exclusive agreement, the companies will offer customers Aragen’s cell line development expertise integrated with Avid’s upstream and downstream process development and analytical services to drive efficiencies and reduce overall timelines for delivering CGMP bulk drug substances.
P r es s R eleas eCo-Marketing Agreement • December 13th, 2002
Kyorin Pharmaceutical Co., Ltd. （HO: Tokyo, President : Ikuo Ogiwara ）and Bayer Yakuhin, Ltd. (HO: Osaka, President: Norikazu Eiki) reached a co -marketing agreement on the anti -allergic rhinitis treatment “Baynas ®” which has been marketed by Bayer Yakuhin since May 2000. Kyorin Pharmaceutical will start to co-market Baynas ® from January 2003 based on the agreement. Sales promotion will be made by both companies under the same brand name and turnover will be counted separately.
Mektovi BINIMETINIBCo-Marketing Agreement • March 1st, 2022
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.
Co-Marketing Agreement This Co-Marketing Agreement ("Agreement") is entered into as of the April, 1998 between Dynamic Imaging Group Inc., a Colorado Corporation, with its principal place of business at 3418 Ocean Boulevard, Fort Lauderdale, Florida...Co-Marketing Agreement • November 15th, 1999 • Dynamic Imaging Group Inc/Fl • Services-business services, nec • Florida
Argonaut’s Clinical Fill-Finish Capabilities to Complement Avid’s Upstream and Downstream Process Development and Biologics Manufacturing Services in Supporting Developers of Biologic TherapeuticsCo-Marketing Agreement • July 28th, 2020
dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, and Argonaut Manufacturing Services, a CGMP contract manufacturing organization (CMO) dedicated to providing custom manufacturing and supply chain solutions for life science, molecular diagnostics, and biopharmaceutical companies, today announced a co-marketing agreement that will provide clients an integrated manufacturing solution including process development, drug substance manufacturing, and drug product manufacturing. Under terms of the non-exclusive agreement, the companies will offer Avid’s upstream and downstream process development and drug substance manufacturing services in tandem with Argonaut’s parenteral drug product fill-finish services, to support the efficient delivery of CGMP parenteral drug products for use in clinical studies.
CO-MARKETING AGREEMENT This Co-Marketing Agreement (the "Agreement") is made and entered into this 18th day of February, 1999 ("Effective Date"), by and between priceline.com Incorporated, a Delaware corporation located at Five High Ridge Park,...Co-Marketing Agreement • March 18th, 1999 • Priceline Com Inc • Services-computer integrated systems design • New York
ContractCo-Marketing Agreement • May 5th, 2020 • New York
EX-10.1 2 wiproco-marketingagreement.htm EXHIBIT 10.1 CO- MARKETING AGREEMENT THIS CO- MARKETING AGREEMENT (“Agreement”) is entered into as of January 23, 2018 by and between: HARTE HANKS, INC, a Delaware corporation with its principal office at 9601 McAllister Freeway, Suite 610; San Antonio, TX 78216, (the “Company,” which shall be deemed to include its successors and assigns to the extent permitted hereunder), and WIPRO, LLC, a Delaware limited liability corporation having its registered office at 2 Tower Center Blvd, Suite 2200; East Brunswick, NJ 08816, USA (“Wipro”, which shall be deemed to include its successors and assigns to the extent permitted hereunder); Each of Wipro and the Company shall be individually referred to as a “Party”, and jointly as the “Parties”. WHEREAS, Wipro is a leading global services provider of global information technology, consulting and business process services (collectively, “Wipro Offerings”); WHEREAS, the Company is a provider of global marketing
CONFIDENTIAL CO-MARKETING AGREEMENTCo-Marketing Agreement • August 14th, 2007 • Hansen Medical Inc • Orthopedic, prosthetic & surgical appliances & supplies • New York
This Co-Marketing Agreement (this Agreement), effective as of April 30, 2007 (the “Effective Date”), is made by and between St. Jude Medical, Inc., a Minnesota corporation with offices at One Lillehei Plaza, Saint Paul, MN 55117 (“St. Jude”), and Hansen Medical, Inc., a Delaware corporation having its principal place of business at 380 North Bernardo Avenue, Mountain View, CA 94043 (“Hansen”).
EXHIBIT 10.2 CO-MARKETING AGREEMENT This Co-Marketing Agreement ("Agreement") is entered into as of the 21st day of August 2003 between and Radix Marine, a Nevada Corporation with its principal place of business at 9119 Ridgetop Blvd., Suite 260,...Co-Marketing Agreement • April 9th, 2004 • Radix Marine Inc • Real estate • Washington
CO-MARKETING AGREEMENT Between SOURCE ATLANTIC, INC. (“SA”) And EMTS, LLC (“EMTS”) June 8, 2004Co-Marketing Agreement • February 11th, 2005 • Source Atlantic, Inc. • Services-facilities support management services
Source Atlantic, Inc. (“SA”), a Delaware corporation having an office at 55 Accord Park Drive, Rockland, MA 02370 and EMTS, LLC, (“EMTS”) a Texas corporation with its principal place of business at 8 Inverness Drive East Suite 245 Englewood, CO 80112 (each a “Party”, and collectively the “Parties”) hereby agree as follows:
Agreement Broadly Applicable to All Therapeutic Areas with Specific Focus on the Growing Psychedelic and Cannabinoid Drug Development MarketsCo-Marketing Agreement • February 1st, 2024
Societal CDMO, Inc. (“Societal CDMO”; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, and Benuvia Operations, LLC, a U.S.-based drug developer and manufacturer of active pharmaceutical ingredients (APIs) with a specialized expertise in controlled substances (cannabinoids and psychedelics), today announced the signing of a co-marketing agreement. The agreement is designed to allow the companies to promote each other’s complementary contract development and manufacturing services to their respective customer bases and new business prospects. As part of the agreement, the companies will highlight Benuvia’s specific expertise as a manufacturer of drug substance (API) and Societal’s focus on manufacturing drug product. While the agreement is not limited to any specific therapeutic indication or modality, the companies will specifically focus
CO-MARKETING AGREEMENT & AFFILIATION AGREEMENTCo-Marketing Agreement • May 15th, 2001 • Future Technologies Inc • Services-business services, nec • British Columbia
BETWEEN: SE GLOBAL EQUITIES INC., a company incorporated under the laws of Cayman Islands having an office at 5507 The Center, 99 Queens Road Central, Hong Kong ("SEG") Facsimile: 852-2169-3029 Telephone: 852-2169-3019
Co-Marketing Agreement BetweenCo-Marketing Agreement • November 15th, 2016
The partners agree to construct a marketing partnership based on mutual respect and trust that leverages the resources of all. Use f parties. The partners listed above hereby agree that they shall be considered co-marketing partners in business for the following purpose:
SOFTWARE CO-MARKETING AGREEMENT This Agreement is entered into by and between Lucent Technologies, Inc., with a place of business at 211 Mt. Airy Rd., Basking Ridge NJ 07920 (hereinafter called LUCENT) and Spanlink Communications, Inc. with a place of...Co-Marketing Agreement • March 31st, 1998 • Spanlink Communications Inc • Telephone & telegraph apparatus
1. PURPOSE OF AGREEMENT 4Co-Marketing Agreement • December 23rd, 1998 • Educational Video Conferencing Inc • Services-educational services • New Jersey
Merial, Boehringer Ingelheim Sign Precondition Co-Marketing AgreementCo-Marketing Agreement • October 19th, 2022
(DULUTH, Ga., January 25, 2005) — Merial and Boehringer Ingelheim Vetmedica, Inc., announce a co-marketing agreement for the Merial Surehealth calf-preconditioning program that will create a more robust offering of eligible products. The Surehealth program features best management practices that add value to feeder calves throughout the production chain.
AMENDMENT NO. 1 TO CO-MARKETING AGREEMENTCo-Marketing Agreement • August 14th, 2007 • Cambridge Heart Inc • Electromedical & electrotherapeutic apparatus
This Amendment No. 1 to Co-Marketing Agreement (the “Amendment”) is entered into on June 18, 2007, effective as of March 21, 2007 between Cambridge Heart, Inc. (“Cambridge”), a Delaware corporation, and St. Jude Medical, Inc. (“SJM”), a Minnesota corporation, and is an amendment to the Co-Marketing Agreement entered into by Cambridge and SJM on March 21, 2007 (the “Agreement”). All capitalized terms used herein and not defined herein shall have the meanings assigned to such terms in the Agreement.
AGILENT TECHNOLOGIES AND BIOTROVE CO-MARKETING AGREEMENTCo-Marketing Agreement • April 1st, 2008 • BioTrove, Inc. • California
CO-MARKETING AGREEMENTCo-Marketing Agreement • June 12th, 2024 • California
This Co-Marketing Agreement (“Agreement”) is made as of [DATE] (the “Effective Date”) by and between the South Bay Cities Council of Governments, a California joint powers authority ("SBCCOG") and Renovate America, Inc. ("Renovate America").
The Evolution of Astra Merck Inc. in 1998 ∗Co-Marketing Agreement • November 29th, 2007
In 1982, Merck & Co. and Astra AB signed an agreement by which products resulting from Astra’s research pipeline would be taken through clinical trials and registration, to be ultimately marketed and sold by Merck in the United States. The initial terms of the contract specified that Astra’s products would be transferred to Merck’s development and marketing organizations, with Astra receiving royalties on the sales of the Astra drugs.1
AGREEMENT TO CO-MARKET PROPERTYCo-Marketing Agreement • March 11th, 2011 • Oregon
This AGREEMENT is entered into as of this day of , 20 , by and between , an Oregon licensed real estate agent affiliated with RE/MAX Equity Group (“Marketing Broker”), and , an Oregon-licensed real estate agent affiliated with (“Listing Broker”).
Skannex and Abingdon Health sign a co-marketing agreementCo-Marketing Agreement • October 15th, 2017
Skannex AS, Oslo, Norway (“Skannex”) and Abingdon Health Limited (“Abingdon”),York, UK and joint- ly announce that both parties have entered into a co-marketing agreement to provide lateral flow assay and reader development and manufacturing solutions to contract customers.
ENEL PARTNERS WITH TRENITALIACo-Marketing Agreement • September 26th, 2011
Trenitalia’s fidelity card offered to Enel Energia customers, electricity consumption converted into Cartafreccia points
Exhibit 10.1 Extension of Co-Marketing Agreement Dated as of December 31, 1999 Pursuant to section 5.1 of the Co-marketing Agreement between Boston Scientific Corporation and Urologix dated August 9, 1999 (the "Agreement"), the term of the Agreement...Co-Marketing Agreement • February 10th, 2000 • Urologix Inc • Electromedical & electrotherapeutic apparatus
Pursuant to section 5.1 of the Co-marketing Agreement between Boston Scientific Corporation and Urologix dated August 9, 1999 (the "Agreement"), the term of the Agreement is hereby extended to March 31, 2000. All other terms and provision of the Agreement shall remain unchanged.
SALESFORCE PARTNER CO-MARKETING AGREEMENTCo-Marketing Agreement • June 15th, 2017
THIS SALESFORCE PARTNER CO-MARKETING AGREEMENT (“AGREEMENT”) SETS FORTH YOUR RIGHTS AND OBLIGATIONS RELATED TO PARTNER-SPONSORED CO-MARKETING ACTIVITIES. BY ACCEPTING THIS AGREEMENT, EITHER BY CLICKING A BOX INDICATING YOUR ACCEPTANCE OR OTHERWISE ELECTRONICALLY INDICATING ACCEPTANCE, YOU AGREE TO THE TERMS OF THE AGREEMENT. IF YOU ARE ENTERING INTO THIS AGREEMENT ON BEHALF OF A COMPANY OR OTHER LEGAL ENTITY, YOU REPRESENT THAT YOU HAVE THE AUTHORITY TO BIND SUCH ENTITY AND ITS AFFILIATES TO THESE TERMS AND CONDITIONS, IN WHICH CASE THE TERMS "YOU" OR "YOUR" SHALL REFER TO SUCH ENTITY AND ITS AFFILIATES. YOU AND SALESFORCE (“SFDC”) AND ARE EACH A “PARTY” AND COLLECTIVELY “PARTIES” TO THIS AGREEMENT.
